Comparative responsiveness of generic and specific quality-of-life instruments
- PMID: 12589870
- DOI: 10.1016/s0895-4356(02)00537-1
Comparative responsiveness of generic and specific quality-of-life instruments
Abstract
We assessed the relative responsiveness of generic and specific quality of life instruments in 43 randomized controlled trials that compared head-to-head 31 generic and 84 specific instruments. Using weighted effect size as the metric of responsiveness, we assessed the impact of instrument type, disease category, and magnitude of underlying therapeutic effect on responsiveness, and assessed the responsiveness of specific instruments relative to the corresponding domains of generic measures. In studies with a nonzero therapeutic effect, specific instruments (mean = 0.57) were significantly more responsive than generic instruments (mean = 0.39, P =.01), and than the corresponding domains of generic instruments (mean = 0.40, P =.03). Studies with low, medium, and high therapeutic effects showed a corresponding gradation in responsiveness differences between specific and generic instruments. We conclude that, overall, specific instruments are more responsive than generic tools, and that investigators may come to misleading conclusions about relative instrument responsiveness if they include studies in which the magnitude of the underlying therapeutic effect is zero.
Similar articles
-
On the generalizability of statistical expressions of health related quality of life instrument responsiveness: a data synthesis.Qual Life Res. 1998 Jan;7(1):11-22. doi: 10.1023/a:1008828720272. Qual Life Res. 1998. PMID: 9481147
-
Responsiveness of disease-specific and generic utility instruments in prostate cancer patients.Qual Life Res. 2007 Apr;16(3):509-22. doi: 10.1007/s11136-006-9132-x. Epub 2006 Nov 8. Qual Life Res. 2007. PMID: 17091359
-
Generic measures of health-related quality of life in ankylosing spondylitis: reliability, validity and responsiveness.Rheumatology (Oxford). 2002 Dec;41(12):1380-7. doi: 10.1093/rheumatology/41.12.1380. Rheumatology (Oxford). 2002. PMID: 12468817
-
Quality of life instruments in the evaluation of new drugs.Pharmacoeconomics. 1992 Feb;1(2):84-94. doi: 10.2165/00019053-199201020-00004. Pharmacoeconomics. 1992. PMID: 10146938 Review.
-
The responsiveness of generic quality of life instruments in rheumatic diseases. A systematic review of randomized controlled trials.J Rheumatol. 1999 Jan;26(1):210-6. J Rheumatol. 1999. PMID: 9918266 Review.
Cited by
-
An empirical comparison of sleep-specific versus generic quality of life instruments among Australians with sleep disorders.Qual Life Res. 2024 Aug;33(8):2261-2274. doi: 10.1007/s11136-024-03686-0. Epub 2024 Jun 24. Qual Life Res. 2024. PMID: 38913275 Free PMC article.
-
Reference Values for the German Version of the Quality of Life after Brain Injury in Children and Adolescents (QOLIBRI-KID/ADO) from a General Population Sample.J Pers Med. 2024 Mar 23;14(4):336. doi: 10.3390/jpm14040336. J Pers Med. 2024. PMID: 38672963 Free PMC article.
-
Final Validation of the Quality of Life after Brain Injury for Children and Adolescents (QOLIBRI-KID/ADO) Questionnaire.Children (Basel). 2024 Apr 5;11(4):438. doi: 10.3390/children11040438. Children (Basel). 2024. PMID: 38671655 Free PMC article.
-
Rasch validation of the short form (8 item) PC-QoL questionnaire and applicability of use as a health state classification system for a new preference-based measure.Qual Life Res. 2024 Jul;33(7):1893-1903. doi: 10.1007/s11136-024-03652-w. Epub 2024 Apr 23. Qual Life Res. 2024. PMID: 38653898 Free PMC article.
-
Impact of treatment adherence and inhalation technique on asthma outcomes of pediatric patients: a longitudinal study.Front Pharmacol. 2024 Mar 13;15:1340255. doi: 10.3389/fphar.2024.1340255. eCollection 2024. Front Pharmacol. 2024. PMID: 38549668 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources